A detailed history of Courier Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Courier Capital LLC holds 43,046 shares of BMY stock, worth $2.48 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
43,046
Previous 44,020 2.21%
Holding current value
$2.48 Million
Previous $1.83 Million 21.83%
% of portfolio
0.15%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$39.66 - $51.75 $38,628 - $50,404
-974 Reduced 2.21%
43,046 $2.23 Million
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $24,552 - $32,323
-610 Reduced 1.37%
44,020 $1.83 Million
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $90,346 - $102,435
-1,883 Reduced 4.05%
44,630 $2.42 Million
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $35,341 - $42,172
-729 Reduced 1.54%
46,513 $2.39 Million
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $157,055 - $175,612
-2,713 Reduced 5.43%
47,242 $2.74 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $480,182 - $533,167
7,537 Added 17.77%
49,955 $3.19 Million
Q1 2023

May 18, 2023

SELL
$65.71 - $74.53 $86,540 - $98,156
-1,317 Reduced 3.01%
42,418 $2.94 Million
Q4 2022

Jan 24, 2023

SELL
$68.48 - $81.09 $23,694 - $28,057
-346 Reduced 0.78%
43,735 $0
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $345 - $204,317
2,659 Added 6.42%
44,081 $3.13 Million
Q2 2022

Jul 20, 2022

BUY
$72.62 - $79.98 $136,525 - $150,362
1,880 Added 4.75%
41,422 $3.19 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $221,328 - $265,392
-3,600 Reduced 8.34%
39,542 $2.89 Million
Q4 2021

Jan 18, 2022

BUY
$53.63 - $62.52 $33,840 - $39,450
631 Added 1.48%
43,142 $2.69 Million
Q3 2021

Oct 14, 2021

BUY
$59.17 - $69.31 $1,420 - $1,663
24 Added 0.06%
42,511 $2.52 Million
Q2 2021

Jul 12, 2021

BUY
$61.91 - $67.42 $63,148 - $68,768
1,020 Added 2.46%
42,487 $2.84 Million
Q1 2021

Apr 12, 2021

BUY
$59.34 - $66.74 $58,865 - $66,206
992 Added 2.45%
41,467 $2.62 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $50,002 - $56,662
866 Added 2.19%
40,475 $2.51 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $9,188 - $10,182
-160 Reduced 0.4%
39,609 $2.53 Million
Q2 2020

Jul 06, 2020

SELL
$54.82 - $64.09 $72,636 - $84,919
-1,325 Reduced 3.22%
39,769 $2.35 Million
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $370,550 - $538,495
-7,986 Reduced 16.27%
41,094 $2.49 Million
Q4 2019

Jan 10, 2020

SELL
$49.21 - $64.19 $73,913 - $96,413
-1,502 Reduced 2.97%
49,080 $3.21 Million
Q3 2019

Oct 04, 2019

SELL
$42.77 - $50.71 $44,951 - $53,296
-1,051 Reduced 2.04%
50,582 $2.51 Million
Q2 2019

Jul 16, 2019

SELL
$44.62 - $49.34 $87,098 - $96,311
-1,952 Reduced 3.64%
51,633 $2.34 Million
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $2,256 - $2,690
-50 Reduced 0.09%
53,585 $2.56 Million
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $61,193 - $79,353
-1,255 Reduced 2.29%
53,635 $2.79 Million
Q3 2018

Oct 12, 2018

BUY
$55.19 - $62.25 $189,412 - $213,642
3,432 Added 6.67%
54,890 $3.41 Million
Q2 2018

Jul 19, 2018

BUY
$50.53 - $62.98 $10,712 - $13,351
212 Added 0.41%
51,458 $2.85 Million
Q1 2018

Apr 27, 2018

BUY
$59.92 - $68.98 $46,977 - $54,080
784 Added 1.55%
51,246 $3.24 Million
Q4 2017

Jan 25, 2018

BUY
$59.94 - $65.35 $6,833 - $7,449
114 Added 0.23%
50,462 $3.09 Million
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $492,927 - $568,879
8,925 Added 21.55%
50,348 $3.21 Million
Q2 2017

Aug 10, 2017

BUY
N/A
41,423
41,423 $2.31 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Courier Capital LLC Portfolio

Follow Courier Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.